Evolution (Buy, TP: SEK1700.00) - Live buying opportunity

We reiterate our BUY and SEK1,700 target price after healthy but in-line Q1 results (Live revenue growth >25% YOY at constant FX). In our view, the weak share price despite a healthy start to the year, promising new games pipeline, high-conviction growth outlook (growth investments, e.g. recruitment), and long-awaited Live dealer contract with leading operator bet365 offers a solid buying opportunity.

Set for acceleration

Expansion investments weigh on Q1 margin, but great setup for solid outlook for remainder of '24e. Keep BUY — 17-14x '25e-'26e P/E and >5% FCF yield

Bet365 signing proving Evo's strength

FLSmidth (Buy, TP: DKK440.00) - Mixed start to the year

Following a rather mixed Q1 report, our 2024–2026e clean EPS are virtually unchanged. We reiterate our BUY and have raised our target price to DKK440 (400) on a slightly raised SOTP multiple approach. We like the continued earnings quality improvement and further value-creation potential through an exit from Cement.

DOF Group (Buy, TP: NOK110.00) - Profiting from solid subsea market

DOF continued its strong execution in Q1, with EBITDA 5% above consensus. Net debt was flat QOQ but this was driven by non-cash lease additions for Maersk Installer, which should start contributing to earnings from Q2. The market keeps improving and management highlighted up to 10 long-term charter opportunities and clients already tendering for project work to be executed in 2027. It targets a refinancing in 2025 and said it aims for 1.5x net debt/EBITDA before paying dividends, which we forecast it should achieve by end-2025. We reiterate our BUY and NOK110 target price.

Lundbeck (Buy, TP: DKK44.00) - Good start to the year

The Q1 results beat our estimates and consensus, with a strong EBIT margin of 24.2%, benefitting from operating leverage. The 2024 guidance was revised on FX for reported revenue growth to c3%-points (c4%-points) lower than in constant exchange rate (CER) terms, and adj. EBITDA growth to c8%-points (c9%-points) lower than in CER. However, in CER terms it was maintained for revenue up 7–10% YOY and adj. EBITDA up 10–16% YOY. We reiterate our BUY and DKK44 target price.